Product Information
ANTACID ULTRA TABLET CHEW is a generic product labeled by AmerisourceBergen, priced at $0.0370 per EA under NDC 24385059523. Its NADAC has been published 188 times since Mar 1, 2023.
Strength
1000 mg/1
Manufacturer
AmerisourceBergenNDC
24385059523
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CALCIUM CARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
part331On Market Since
10/1/2016
Pharmacological Classes
Price Statistics
The NADAC for ANTACID ULTRA TABLET CHEW has been published 188 times since Mar 1, 2023, and over the history we have for it it has risen 6.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0370 per EA |
|---|---|
| All-time high | $0.0373 (Jun 10, 2026) |
| All-time low | $0.0324 (Oct 18, 2023) |
| 52-week high | $0.0373 |
| 52-week low | $0.0358 |
| Median price | $0.0361 |
| Average price | $0.0359 |
| Largest weekly change | -7.7% (Oct 18, 2023) |
| Weeks tracked | 188 |
| Tracking since | Mar 1, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcium carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Blood Coagulation Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANTACID ULTRA TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for ANTACID ULTRA TABLET CHEW, manufactured by AmerisourceBergen, is $0.0370 per EA (NDC 24385059523), effective Sep 30, 2026.
How has the price of ANTACID ULTRA TABLET CHEW changed over time?
Over the history we have for it, the NADAC for ANTACID ULTRA TABLET CHEW has risen 6.6%. It has been tracked across 188 weekly CMS publications since Mar 1, 2023.
What are the highest and lowest recorded NADAC prices for ANTACID ULTRA TABLET CHEW?
Since Mar 1, 2023, the NADAC for ANTACID ULTRA TABLET CHEW has ranged from a low of $0.0324 (Oct 18, 2023) to a high of $0.0373 (Jun 10, 2026), with a median of $0.0361 per EA.
Are there cheaper alternatives to ANTACID ULTRA TABLET CHEW?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ANTACID ULTRA STR 1,000 MG CHW, is $0.0370 per EA — about 0% below ANTACID ULTRA TABLET CHEW.
Who manufactures ANTACID ULTRA TABLET CHEW?
ANTACID ULTRA TABLET CHEW (NDC 24385059523) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.